Internal Medicine, Rheumatology · Farmington Hills, MI
NPI
1154306710
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
32255 Northwestern Hwy Ste 120
Farmington Hills, MI, 48334
Phone (248) 350-3190
Groups this clinician bills Medicare through
Medicare paid, 2024
$306K
24,438 services
Medicare patients, 2024
419
Average age 72
Drug cost, 2024
$3.1M
3,272 prescriptions
Company payments, 2025
$2,001
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parveen Qazi was code J1602 (injection, golimumab, 1 mg, for intravenous use), 12,500 times for 15 patients. In total Parveen Qazi billed 24,438 services in 46 codes, and Medicare paid $306K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,500 | 15 | $9.00 | $112K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,782 | 93 | $0.10 | $563 |
| 99214 Office E&M - Established | Office | 538 | 296 | $88.47 | $48K |
| 73130 X-ray - Upper Extremity | Office | 243 | 123 | $26.05 | $6,331 |
| 20610 Joint Injection | Office | 228 | 96 | $42.00 | $9,575 |
| 36415 Venipuncture Blood Collection | Office | 185 | 148 | $4.80 | $888 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 161 | 109 | $12.96 | $2,087 |
| 99213 Office E&M - Established | Office | 151 | 108 | $63.03 | $9,518 |
| 73562 X-ray - Lower Extremity | Office | 108 | 61 | $28.94 | $3,126 |
| 96365 Intravenous Infusion, Hydration | Office | 105 | 20 | $48.65 | $5,108 |
| 73030 X-ray - Upper Extremity | Office | 92 | 57 | $25.95 | $2,387 |
| 99204 Office E&M - New | Office | 79 | 79 | $118.95 | $9,397 |
| 73630 X-ray - Lower Extremity | Office | 78 | 41 | $25.84 | $2,016 |
| 72050 X-ray - Spine and Pelvis | Office | 27 | 27 | $37.81 | $1,021 |
| 72110 X-ray - Spine and Pelvis | Office | 24 | 24 | $34.27 | $823 |
By year: 2022 $252K for 14,370 services; 2023 $282K for 15,264 services; 2024 $306K for 24,438 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 185 | 148 | $4.80 | $888 |
Medicare prescription drug claims, 2024
In 2024, the drug Parveen Qazi prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 695 prescriptions and refills. In total Parveen Qazi wrote 3,272 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 695 | 1,654 | 187 | $43K |
| Prednisone Generic | 490 | 844 | 125 | $4,577 |
| Methotrexate Methotrexate Sodium | 331 | 657 | 82 | $10K |
| Methylprednisolone Generic | 193 | 240 | 106 | $2,309 |
| Meloxicam Generic | 150 | 277 | 45 | $464 |
| Gabapentin Generic | 94 | 186 | 30 | $850 |
| Famotidine Generic | 93 | 216 | 36 | $1,156 |
| Otezla Apremilast | 87 | 87 | Under 11 | $414K |
| Humira(Cf) Pen Adalimumab | 77 | 77 | Under 11 | $871K |
| Celecoxib Generic | 73 | 161 | 22 | $1,591 |
| Leflunomide Generic | 73 | 134 | 13 | $3,722 |
| Allopurinol Generic | 62 | 153 | 19 | $798 |
| Pregabalin Generic | 60 | 120 | 16 | $1,066 |
| Folic Acid Generic | 60 | 170 | 20 | $498 |
| Enbrel Sureclick Etanercept | 51 | 51 | Under 11 | $360K |
Brand drugs: - claims; generic drugs: 2,790 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parveen Qazi $2,001 ($2,001 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $501.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $501 |
| Janssen Biotech, Inc. JNJ | 30 | $353 |
| Amgen Inc. AMGN | 22 | $308 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $305 |
| UCB, Inc. UCB.BR | 8 | $284 |
| GlaxoSmithKline, LLC. GSK | 5 | $93.72 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $55.9 |
| Organon LLC OGN | 2 | $48.18 |
| Pfizer Inc. PFE | 1 | $21.02 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $16.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.